Improving Cervical Cancer Prevention among Women Living with Chronic Conditions

This clinical trial tests how well a patient navigation for the prevention of cervical cancer intervention (PINPOINT) works to improve cervical cancer screening among women living with chronic conditions. Each year in the United States, 4,000 women unnecessarily die of cervical cancer. Cervical cancer is preventable via screening. Screening includes testing for human papillomavirus (HPV), the leading risk factor for cervical cancer, or a cervical cytology test (pap smear) that allows for examining the cervix for abnormalities or precancerous cells. To achieve the goal of eliminating cervical cancer in the United States by 2050, it is imperative to address barriers to cervical cancer screening through the implementation of evidence-based strategies that have been shown to improve screening. Cervical cancer screening self-collection tests allow women to collect their own samples to be tested and have been shown to yield results comparable to clinician collected samples completed in the clinic, increase screening rates, and are preferred among under-screened women.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07351110.

Trial PhaseNo phase specified

Trial Typescreening

Lead OrganizationUF Health Cancer Institute - Gainesville

Principal InvestigatorRahma S. Mkuu

• Primary IDUF-CCPS-042
• Secondary IDsNCI-2026-03768, IRB202500780, OCR47903
• ClinicalTrials.gov IDNCT07351110